Indications
Therapeutic Asset Ratings
6,305 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
SX682
Colorectal Carcinoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
SX682
Salivary Gland Cancer
National Cancer Institute (NCI)
P1/2
CC
(47)
SX682
Rectal Cancer
M.D. Anderson Cancer Center
P1/2
CC
(47)
Tagraxofusp
Hematopoietic And Lymphoid System Neoplasm
Jacqueline Garcia, MD
P1/2
CC
(47)
Tak-500
Hepatocellular Carcinoma
Takeda
P1/2
CC
(47)
Tak-500
Nasopharyngeal Carcinoma
Takeda
P1/2
CC
(47)
Tarlatamab
Esthesioneuroblastoma
University of Arizona
P1/2
CC
(47)
Tarlatamab
Pulmonary Large Cell Neuroendocrine Carcinoma
University of Arizona
P1/2
CC
(47)
Tarlatamab
Small Cell Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Tazemetostat Hydrobromide
Cutaneous Melanoma
National Cancer Institute (NCI)
P1/2
CC
(47)
tc-510
Ovarian Serous Adenocarcinoma
TCR2 Therapeutics
P1/2
CC
(47)
tcc1727
Gastric Cancer
Beijing Tide Pharmaceutical Co., Ltd
P1/2
CC
(47)
Tcr Reserved And Power3 (Sppl3) Gene Knock-Out Allogeneic Cd19-Targeting Car-T Cell
Acute Lymphoblastic Leukemia
Chinese PLA General Hospital
P1/2
CC
(47)
Tegavivint
Colorectal Cancer
HonorHealth Research Institute
P1/2
CC
(47)
Tegavivint
Wilms Tumor
Children's Oncology Group
P1/2
CC
(47)
Telmisartan
Doxorubicin Induced Cardiomyopathy
Tanta University
P1/2
CC
(47)
Temuterkib
Colorectal Carcinoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
Temuterkib
Rectal Cancer
M.D. Anderson Cancer Center
P1/2
CC
(47)
Terazosin
Lewy Body Dementia
Qiang Zhang
P1/2
CC
(47)
Tgm-312-Sc01
Metabolic Dysfunction-Associated Steatohepatitis
Tangram Therapeutics Plc
P1/2
CC
(47)
Therapeutic 4Scar19 Cells
B-Cell Non-Hodgkin Lymphoma
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(47)
TIL
Meningioma
Essen Biotech
P1/2
CC
(47)
Tilt-123
Fallopian Tube Carcinoma
TILT Biotherapeutics Ltd.
P1/2
CC
(47)
Tilt-123
Primary Peritoneal Carcinoma
TILT Biotherapeutics Ltd.
P1/2
CC
(47)
Tinengotinib
Clear Cell Renal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
P1/2
CC
(47)
Showing 2651 to 2675 of 6,305 assets
Previous
Page 107 of 253
Next